BA
ADMS

BlackRock Advisors’s Adamas Pharmaceuticals ADMS Stock Holding History

BlackRock Advisors’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$143K Buy
8,489
+180
+2% +$2.78K ﹤0.01% 2880
2016
Q3 		$136K Buy
8,309
+774
+10% +$11.8K ﹤0.01% 2883
2016
Q2 		$114K Sell
7,535
-30,985
-80% -$511K ﹤0.01% 2903
2016
Q1 		$557K Buy
38,520
+2,731
+8% +$46K ﹤0.01% 2020
2015
Q4 		$1.01M Sell
35,789
-9,148
-20% -$154K ﹤0.01% 1702
2015
Q3 		$752K Sell
44,937
-4,570
-9% -$104K ﹤0.01% 1902
2015
Q2 		$1.3M Buy
49,507
+2,332
+5% +$45.4K ﹤0.01% 1490
2015
Q1 		$825K Buy
47,175
+46,002
+3,922% +$788K ﹤0.01% 1685
2014
Q4 		$20K Sell
1,173
-96,300
-99% -$1.46M ﹤0.01% 3509
2014
Q3 		$1.81M Sell
97,473
-9,200
-9% -$158K ﹤0.01% 1201
2014
Q2 		$1.95M Buy
+106,673
New +$1.91M ﹤0.01% 1185

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock Advisors's ADMS Position: Q4 2016 in Review

BlackRock Advisors increased its Adamas Pharmaceuticals (ADMS) stake by 2.2% in Q4 2016, buying an estimated $2.78K and bringing the position to 8,489 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #2880.

BlackRock Advisors first reported a position in ADMS in Q2 2014 and has held it in 11 quarters since. The position peaked at $1.95M in Q2 2014. 78 funds tracked by Wall St. Rank hold ADMS as of Q4 2016.

  • BlackRock Advisors held 8,489 shares of Adamas Pharmaceuticals worth $143K as of Q4 2016.
  • BlackRock Advisors bought 180 Adamas Pharmaceuticals shares in Q4 2016, an estimated $2.78K.
  • Adamas Pharmaceuticals made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2880 holding.
  • BlackRock Advisors first reported a position in Adamas Pharmaceuticals in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Advisors's Adamas Pharmaceuticals position peaked at $1.95M in Q2 2014.
  • 78 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.